Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

Phase 4
2(50.0%)
N/A
2(50.0%)
4Total
Phase 4(2)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials
NCT07290699Phase 4Not Yet Recruiting

Intensive Cholesterol-Lowering Within 24 Hours of PCI Perioperative Period

Role: collaborator

NCT07153744Phase 4Not Yet Recruiting

Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction

Role: collaborator

NCT06078930Recruiting

Development of Novel Gastric Cancer Screening and Diagnosis Technologies Using Tongue Imaging and Study of Tongue Image Changes Mechanisms

Role: collaborator

NCT05198154Recruiting

ctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLC

Role: collaborator

NCT06331923Not ApplicableRecruiting

Assessing the Effectiveness of Continuous Glucose Monitoring in Enhancing Surgical Outcomes for Patients with Diabetes

Role: collaborator

NCT05598528Recruiting

Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study)

Role: collaborator

NCT04793672Completed

Establishment of Tongue Image Database and Machine Learning Model for Malignant Tumors Diagnosis

Role: collaborator

NCT06162780Recruiting

TEER for Severe DMR of Low to Intermediate Surgery Risk

Role: collaborator

NCT05651893Not ApplicableUnknown

Efficacy of Second Forward-view Examination of Left Colon for Adenoma Detection During Colonoscopy

Role: collaborator

All 9 trials loaded